Lannett Company, Inc. announced the appointment of Maureen M. Cavanaugh to the newly created position, senior vice president and chief commercial operations officer, effective May 7, 2018. In this role, Cavanaugh will be responsible for sales and marketing, research and development (R&D) and regulatory affairs. For the last 11 years, Cavanaugh worked for Teva Pharmaceuticals USA, most recently as senior vice president, chief commercial officer, North America Generics, where she had oversight responsibility for leading trade sales, new product planning and portfolio management teams, as well as the long range planning and strategy development processes for the company's U.S. generics business. In conjunction with the appointment of Cavanaugh, the company re-aligned management responsibilities to further strengthen operational execution and empowerment. John Kozlowski has been named chief of staff and strategy officer and John Abt, DBA, has been promoted to vice president and chief quality and operations officer. Kozlowski, who joined Lannett in 2009 and most recently served as chief operating officer, will be responsible for business development, strategy, project management and human resources. Dr. Abt, who has served for the last three years as vice president of quality and previously served as vice president of U.S. operations for Teva, will now have overall responsibility for production, supply chain and quality.